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1. Introduction 
During protein synthesis GTP hydrolysis occurs at 
the initiation and elongation steps [l] ; it has also 
been shown at the termination step in eukaryotic 
cells [2] . A GTP hydrolysis not coupled with protein 
synthesis (in the absence of mRNA and tRNA) can 
also be observed: whereas in the presence of either 
ribosome or any factor alone very little GTP hydrolysis 
can be observed, significant hydrolysis occurs in the 
presence of ribosomes and one of the factors involved 
in any one of the steps: initiation factor IF-2, or 
elongation factor EF-G [3] , or termination factor 
TF-R in eukaryotic cells [4-61. Some ribosome- 
dependent GTP hydrolysis also occurs in thermophilic 
bacteria in the presence of EF-Tu [7] . 
The significance of these uncoupled GTP hydrolyses 
is not clear. 
Two groups of inhibitors of the factor and ribo- 
some dependent GTP hydrolysis are known: the first, 
fusidic acid, prevents EF-G-dependent GTP hydrolysis 
by stabilizing the ternary complex: ribosome-EF-G- 
GDP (which is formed after one round of EF-G- 
promoted GTP hydrolysis), thus blocking any further 
GTP hydrolysis [8,9]. This antibiotic has no effect 
on the ribosomal GTPase promoted by IF-2 [S] , EF-T 
[7], or TF-R [2]. The second group includes thiostrep- 
ton and siomycin. These antibiotics inhibit EF-G and 
EF-T-dependent GTP hydrolysis by quite a different 
mechanism: they irreversibly inactivate the binding site 
for EF-G, thus preventing the formation of the ribo- 
* A preliminary report was given in a lecture delivered at a 
Symposium of the Soci& de Chimie Biologique [ 251. 
North-Holland Publishing Company - Amsterdam 
some-EF-G-GTP (or GDP) complex [lo-l 31. These 
antibiotics also prevent binding of aminoacyl-tRNA 
to the A site [ 141 . Moreover, siomycin-treated ribo- 
somes cannot exhibit the GTPase activity associated 
with EF-G, nor that associated with EF-T [14]. These 
effects seem to result from a single action of siomycin 
on the 50 S ribosome subunit, suggesting a relation- 
ship between EF-G binding site and that of the 
aminoacyl-tRNA-EF-Tu-GTP complex. 
Neither siomycin nor thiostrepton bind to the 30 S 
subunits, and the reported lack of inhibition of 
&let-tRNA binding [ 141 by thiostrepton supports 
the view that during initiation this tRNA does not go 
through the A site on the ribosome [15, 161. In the 
present communication we report that, despite its 
failure to inhibit flvlet-tRNA binding, thiostrepton 
does inhibit the GTPase activity catalyzed by IF-2. 
2. Materials and methods 
Ribosomes washed with ammonium chloride (M) 
and purified initiation factors, IF-1 and IF-2 from 
E. coli MRE 600, were prepared as described else- 
where [5]. 
Elongation factors, EF-T(Tu+Ts) and EF-G were 
prepared in our laboratory by M. Springer, as 
described previously [ 171. 
Unfractionated E. coli B tRNA (General Bio- 
chemicals) was charged with 3H-methionine (specific 
activity, 1 Ci/mmole) and formylated; or charged with 
14C-phenylalanine (specific activity, 235 mCi/mmole) 
according to the method already described [5]. The 
labelled amino acids were products of C .E .A., Saclay, 
France. 
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Binding of aminoacyl-tRNA to ribosomes was 
assayed by filtration on nitrocellulose filters. 
GTPase activity was assayed as already described 
[51 . 
Thiostrepton was added to saturation in dimethyl 
sulphoxide (Me,SO, 20%), consequently between 4 
and 5% Me,SO was present in the reaction mixture 
with the antibiotic. The effect of Me,SO will be dis- 
cussed in the results. 
Poly A, U, G, poly U, and ApUpG were synthesized 
by polynucleotide phosphorylase in the usual manner 
P81. 
Fusidic acid, sodium salt, was a gift from Laboratoire 
Leo, Paris, and thiostrepton was a gift from Dr. 
Modolell; we are grateful to both. 
Table 1 
Puromycin reaction and streptomycin action on fMet-tRNA 
bound to ribosomes in the presence of thiostrepton. 
-- 
pmoles of fMat-tRNA bound or of 
IMet-puromycin extracted 
Additions 
Experiment 1 
-pure +puro 
Experiment 2 
-Sm +Sm * 
~- 
None 
Me@ 4% 
(final cont.) 
6.90 7.59 1.08 0.539 
7.62 8.30 2.45 1.16 
Me2S0 4% + 
thiostrepton 
(0.005 mM) 
7.69 8.8 1.67 0.9 
The incubation mixture (50 ~1) contained: Tris (pH 7.5), 50 
mM; Mg acetate, 5 mM; NH&l, 80 mM; GTP, 1 mM; ribosome, 
1 A260 unit; IF-l, 3.8 pg. Experiment 1: poly AUG, 0.15 A260 
unit; IF-2, 2.45 pg; 3H-fMet-tRNA (13.5 pmoles/A26o unit), 
0.75 A260 unit. Incubation 10 min at 37”. Where indicated 
100 ~1 of 70 mg % puromycin were added after incubation, 
and after 5 min at 37” the samples were diluted with 1 ml of 
ethyl acetate solution (pH 5) 0.1 M, and puromycin extracted 
according to Leder and Bursztyn, Biochem. Biophys. Res. 
Commun. 25 (1966) 233. Experiment 2: ApUpC, 0.05 Az60 
unit; IF-2, 15.6 fig; 3H-fMet-tRNA (24.7 pmoles/A260 unit), 
0.98 A260 unit. Incubation 20 min at 37”. Where indicated 
1 fig of streptomycin was added and a further incubation of 
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IO min at 37” was carried out. 
3. Results 
3.1. Lack of effect of thiostrepton on initiation 
Like siomycin, thiostrepton, in solution in 
Me,SO, does not inhibit the binding of 3H-fMet-tRNA 
to 70 S washed ribosomes stimulated by IF-1 + IF-2, 
even in 5 to IO-fold excess (in molar equivalents). The 
fMet-tRNA bound in the presence of thiostrepton 
reacts with puromycin, and is released by streptomycin; 
this indicates that the antibiotic does not interfere 
with fMet-tRNA binding at P site (table 1). By con- 
trast, and confirming previous reports, Phe-tRNA 
binding stimulated by EF-T is inhibited by thiostrep- 
ton (data not shown). In the absence of the antibiotic, 
Me,SO alone stimulates the binding of fMet-tRNA 
and of Phe-tRNA to about the same extent. 
Fig. 1. GTP hydrolysis as a function of factor concentrations. 
The incubation mixture (25 ~1) contained: Tris (pH 7.4), 
50 mM; NH&I, 80 mM; Mg acetate, 10 mM; /3-mercapto- 
ethanol, 7 mM; 70 S ribosomes, 1 A260 units; 32P-GTP, 720 
pmoles (specific activity: 2.14-0.88 Ci/mmole); IF-2 and 
EF-G, as indicated. GTP hydrolysis was determined as 
,already described [5] Incubation IO min at 37”. 
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EF-G 
Fig. 2. Thiostrepton inhibition of EF-G and IF-2 mediated 
and M.A. Wiswanit, Nature 225 (1970) 233. 
GTPase. Same conditions as in fig. 1, except for IF-2, 2.45 
pg; EF-G, 0.3 pg; and thiostrepton in MeaS solution, as 
indicated. The final MezSO concentration was always kept 
inferior to 2%; under these conditions no appreciable GTPase 
stimulation occurs. Inhibition was calculated as compared to 
the sample without MesSO. The molecular weight of thiostrep- 
ton was taken as 1616 according to B. Anderson, D.C. Hodgkin 
3.2. Inhibition of IF-2- and EF-G-dependent GTPase 
by thiostrepton 
Fig. 1 shows IF-2 and EF-G-dependent ribosomal 
GTPase as a function of factor concentrations; very 
little GTPase is exhibited by factor alone or by ribo- 
some alone. It should be noted that at low IF-2 con- 
centrations the curve is not linear. Fig. 2 shows the 
inhibition of the two GTPases as a function of thio- 
strepton concentration: both GTPases are inhibited to 
about the same extent by approx. 1 molar equivalence 
Table 2 
Influence of MeaS on the IF-2-and EF-G-dependent GTPase. 
Additions 
MeaS (final concentration) 
0 4% 8% 
(pmoles Pi liberated) 
Rib. 11.8 11 14 
IF-2 0 0 0 
Rib. + IF-2 70 140 164 
Rib. + IF-2 + IF-1 64 - 103 
EF-G 12 12 12 
Rib. + EF-G 50 110 103 
Same conditions as in fig. 1 except for the amount of 
IF-1 = 3.6 pg. 
Table 3 
Relation between IF-2- and EFGdependent GTPase. 
- ----- 
Addition 
Pi liberated 
(pmoles) 
-- - 
Rib. + EF-G + fus. 162 
Rib. + EF-G 785 
Rib. + IF-2 + fus. 133 
Rib. + IF-2 133 
Rib. + IF-2 + fus. + EF-G 203 
- -__ 
Same conditions as in fig. 1, except that where indicated 
1 mM of sodium fusidate was added to the incubation mixture. 
IF-2-dependent GTPase corresponds to 41 pmoles of Pi 
liberated (after subtraction of EF-G-dependent GTPase). 
of thiostrepton to ribosome. Me,SO, on the other 
hand, at a cont. above 2% highly stimulates both 
GTPases to about 100% (table 2). IF-l, as already 
noted, slightly inhibits the IF-2-dependent GTPase; 
the inhibition is more pronounced at 8% Me,SO. 
3.3. Inhibition of IF-2-dependent GTPase by the 
complex: EF-G-GDP-fusidic acid 
Since thiostrepton is believed to inactivate the EF-G 
binding site, and inhibits the IF-2-dependent GTPase, 
suggesting that the antibiotic binding site is involved 
in this GTPase, we further investigated whether the 
elongation factor-dependent GTP binding site on the 
50 S subunit was involved in the initiation factor- 
dependent GTPase. 
Table 4 
Inhibition by EFC of EF-T-dependent Phe-tRNA binding. 
__-- 
Additions 
pmoles of Phe-tRNA bound 
+GTP +GMP-PCP 
Rib. + fus. 
Rib. + fus. + EF-T 
Rib. + fus. + EF-G 
Rib. + fus. + EF-G + EF-T 
0.34 0.26 
0.97 0.50 
0.30 0.24 
0.64 0.25 
- 
The reaction mixture (50 ~1) contained: Tris (pH 7.5), 50 
mM; NH&l, 80 mM; Mg acetate, 5 mM; GTP, 1 mM; ribosomes, 
1 Azeo unit; IF-2, 2.5 I.rg; sodium fusidate, 1.2 mM; 14C-Phe- 
tRNA (13,000 cpm/Aaeo unit), 1 Aaeo unit; where indicated: 
EF-G, 14.5 pg, and EF-T, 2 pg. A preincubation of 5 min 
was carried out at 25” without EF-T nor Phe-tRNA in 40 pl, 
then the two products were added, the samples were com- 
pleted to 50 ~1 and further incubated 20 min at 25”. 
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The EF-G site was therefore occupied by formation 
of a stable complex: EF-G-GDP-fusidic acid-ribo- 
some, and the initiation factor-dependent ribosomal 
GTPase was investigated. Fusidic acid, while inhibiting 
the elongation factor-dependent GTPase, does not 
inhibit, as previously shown, the initiation factor- 
dependent GTPase; however, addition of EF-G strongly 
inhibits this last GTPase. Table 3 shows that in the 
presence of fusidic acid (after subtracting the residual 
EF-G-dependent GTPase from the initiation factor- 
dependent GTPase), only 40 pmoles of phosphate are 
liberated from GTP, whereas in the absence of EF-G, 
133 pmoles are liberated. In the absence of fusidic 
acid, EF-2-dependent GTPase is somewhat inhibited 
by EF-G at saturating concentrations, but to a much 
lesser extent than when fusidic acid is present. 
3.4. Inhibition of EF-T-stimulated Phe-tRNA binding 
by the complex: GMP-PCP-EF-G-ribosome- 
fusidic acid 
It has been postulated that the EF-G binding site 
was the recognition site, A [ 141 ; we therefore in- 
vestigated whether the the stable complex: EF-G-GTP 
(or GDP)-ribosome-fusidic acid would prevent the 
binding of aminoacyl-tRNA. In order to avoid any 
residual polymerization, the experiment was also per- 
formed in the presence of GMP-PCP, a non-hydrolyz- 
able analog of GTP. 
As can be seen from table 4 the binding of Phe- 
tRNA is strongly inhibited by the presence of fusidic 
acid and of EF-G, confirming that the binding site of 
this factor overlaps the A site. 
4. Discussion 
Blocking EF-G binding site (either by thiostrepton 
or by the complex EF-G-GDP-fusidic acid) prevents 
binding of Phe-tRNA-EF-Tu-GTP to the 50 S ribo- 
some subunit, suggesting that the elongation factors 
(EF-G and EF-T) binding site could be correlated to 
the recognition site, A; moreover, such a blocking 
inhibits the initiation factor-dependent GTPase. 
One can therefore conclude that, although the ribo- 
somal attachment site for the elongation factors is on 
the 50 S subunit [lo-131 and that for initiation 
factors on the 30 S subunit [ 19-211 , a topographical 
relationship exists together with a certain degree of 
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interdependence between the target of IF-2 on the 
70 S ribosomal initiation complex and the reactive 
site of elongation factors. 
One of the explanations would be that IF-2- 
dependent GTP hydrolysis is correlated with the 
exit of this factor from the ribosome which would 
take place on a site on the 50 S identical with, or 
overlapping, the recognition site A. Our data are 
consistent with the hypothesis of Benne and Voorma 
[22] that when GTP is replaced by its non-hydrolyzable 
analog, GMP-PCP, the initiation factor cannot be 
removed from the ribosome and blocks the A site, 
thus explaining the lack of puromycin reactivity of 
the bound fMet-tRNA in the presence of the analog. 
The observed inhibition of Phe-tRNA binding by 
IF-2 is also in favor of this hypothesis [23]. 
Another explanation not exclusive of the former, 
is that GTP hydrolysis results from a conformational 
change of one of the ribosomal subunits, leading to 
the creation of more affinity sites for GTP. This 
could be caused by interaction between elongation 
factor, EF-G, and the 50 S ribosome subunit, or by 
interaction of initiation factor, IF-2, and the 30 S 
subunit. It has already been shown that the presence 
of 30 S subunits enhances the peptidyl transferase 
activity carried by the 50 S [24] . It is also not ex- 
cluded that IF-2 mediated GTP hydrolysis takes 
place on the 30 S subunit, but attachment of an 
antibiotic, or of EF-G in a stable way, on the 50 S 
subunit (as by a GDP-fusidic acid complex) could 
interfere with the 30 S subunit conformational change 
responsible for GTP hydrolysis. The fact that a 
solvent, such as Me,SO stimulates the factor- 
dependent GTPase, and that IF-1 somewhat prevents 
this stimulation, would suggest hat a conformational 
change of ribosome is involved in GTP hydrolysis. In 
any case, our experiments indicate that the factor- 
mediated reaction has a long range effect on the 
subunit complementary to the one at the level of 
which this reaction occurs. 
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